Position in VERA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$124,012,431
-$12,698,120 QoQ
Shares Held
2,890,059
-15.0% QoQ
Ownership
4.01%
of shares outstanding
% of Portfolio
6.85%
of 13F equity value
Holder Rank
#7
of 217 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kynam Capital Management, LP holds $1,765,169,848 across 29 Biotechnology names. VERA ranks #5 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CLDX |
Celldex Therapeutics, Inc.
|
5,322,908 | $198,065,406 | |
| 2 | SNDX |
Syndax Pharmaceuticals Inc
|
8,050,959 | $175,993,963 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
2,922,335 | $169,875,333 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
3,667,097 | $141,916,653 | |
| 5 | VERA |
Vera Therapeutics, Inc.
This page
|
2,890,059 | $124,012,431 | |
| 6 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,453,877 | $118,557,720 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,000,000 | $113,620,000 | |
| 8 | BEAM |
Beam Therapeutics Inc.
|
2,840,792 | $97,495,981 |
All Filings in VERA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0 | 0 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $124,012,431 | 2,890,059 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $136,710,551 | 3,398,224 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $173,849,702 | 3,433,051 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $117,047,868 | 4,027,800 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $80,737,457 | 3,426,887 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $80,737,457 | 3,426,887 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $57,648,000 | 2,400,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $61,655,013 | 1,457,910 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $69,683,465 | 1,576,549 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $55,849,944 | 1,543,669 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $65,835,055 | 1,526,787 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $56,142,213 | 3,650,339 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $40,527,486 | 2,956,053 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $48,150,000 | 3,000,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $26,170,041 | 3,372,428 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $27,266,046 | 1,409,098 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $32,736,017 | 1,536,181 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,724,110 | 1,522,712 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,799,684 | 502,328 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,772,157 | 253,449 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||